ID

29859

Descrizione

Study ID: 104864-201 Clinical Study ID: 104864/A201 Study Title: A Phase III, Open-Label, Multicenter, Randomized, Comparative Study of Topotecan, Ara-C and G-CSF (TAG) versus Idarubicin, Ara-C and G-CSF (IDAG) in MDS Patients with RAEB (High-Risk), RAEB-t or in Patients with AML from a Preceding Phase of MDS Patient Level Data: Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: topotecan Trade Name: hycamtin Study Indication: Myelodysplastic Syndrome https://www.gsk-clinicalstudyregister.com/study/104864/201?search=study&#rs

collegamento

https://www.gsk-clinicalstudyregister.com/study/104864/201?search=study&#rs

Keywords

versioni (1)
  1. 24/04/18 24/04/18 - Halim Ugurlu
Titolare del copyright

GSK

Caricato su

24 aprile 2018

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

GSK Study ID 104864-201 Adverse Experiences (non-serious)

Inglese

Adverse Experiences (non-Serious)

1 moduli  
Identification Numbers
Descrizione

Identification Numbers

Alias
UMLS CUI-1
C1300638
Center Number
Descrizione

Center Number

Tipo di dati

text

Alias
UMLS CUI [1,1]
C1301943
UMLS CUI [1,2]
C0600091
Patient Number
Descrizione

Patient Number

Tipo di dati

text

Alias
UMLS CUI [1]
C1830427
Patient Initials
Descrizione

Patient Initials

Tipo di dati

text

Alias
UMLS CUI [1]
C2986440
Adverse Experiences (non-Serious)
Descrizione

Adverse Experiences (non-Serious)

Alias
UMLS CUI-1
C1518404
If no adverse experiences occurred during the study, please sign form below and mark this box
Descrizione

No Advers Experiences

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C1298908
Serious adverse experience
Descrizione

If you consider this to be a serious adverse experience (SAE), please do not enter on this page but enter in the SAE section in the back of this binder (See tab for definitions of an SAE).

Tipo di dati

text

Alias
UMLS CUI [1]
C1519255
Adverse Experiences (non-Serious)
Descrizione

Adverse Experiences (non-Serious)

Alias
UMLS CUI-1
C1518404
Adverse Experience
Descrizione

Record any adverse experiences (using standard medical terminology ) observed or elicited by the following direct question to patient: "Do you feel different in any way since starting the treatment or since the last visit ?" Provide the diagnosis not symptoms where possible. Enter one adverse experience per column

Tipo di dati

text

Alias
UMLS CUI [1]
C0877248
Onset Data and Time
Descrizione

Onset Data and Time

Tipo di dati

datetime

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C0040223
End Date and Time (if ongoing please leave blank)
Descrizione

End Date and Time (if ongoing please leave blank)

Tipo di dati

datetime

Alias
UMLS CUI [1]
C2981425
Outcome- If patient died, STOP: go to SAE section and follow instructions given here
Descrizione

Outcome

Tipo di dati

text

Alias
UMLS CUI [1]
C1705586
Experience Course
Descrizione

Experience Course

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0750729
Common Toxicity Grade: 1-4
Descrizione

Common Toxicity Grade

Tipo di dati

text

Alias
UMLS CUI [1]
C2826262
Action Taken with Respect to Investigational Drug
Descrizione

Action Taken with Respect to Investigational Drug

Tipo di dati

text

Alias
UMLS CUI [1]
C2826626
Relationship to Investigational Drug
Descrizione

Relationship to Investigational Drug

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0439849
UMLS CUI [1,2]
C3854006
If ´Yes´ record details in the Concomitant Medication section
Descrizione

Corrective Therapy

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0087111
Was patient withdrawn due to this specific AE?
Descrizione

Withdrawn due to this specific AE

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0422727
UMLS CUI [1,2]
C1518404
Investigators Signature
Descrizione

Investigators Signature

Tipo di dati

text

Alias
UMLS CUI [1]
C2346576
Investigators Signature Date
Descrizione

Investigators Signature Date

Tipo di dati

date

Alias
UMLS CUI [1]
C0807937
Ritorna all'inizio della pagina

Similar models

Adverse Experiences (non-Serious)

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Identification Numbers
C1300638 (UMLS CUI-1)
Center Number
Item
Center Number
text
C1301943 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Patient Number
Item
Patient Number
text
C1830427 (UMLS CUI [1])
Patient Initials
Item
Patient Initials
text
C2986440 (UMLS CUI [1])
Item Group
Adverse Experiences (non-Serious)
C1518404 (UMLS CUI-1)
No Advers Experiences
Item
If no adverse experiences occurred during the study, please sign form below and mark this box
boolean
C0877248 (UMLS CUI [1,1])
C1298908 (UMLS CUI [1,2])
Serious adverse experience
Item
Serious adverse experience
text
C1519255 (UMLS CUI [1])
Item Group
Adverse Experiences (non-Serious)
C1518404 (UMLS CUI-1)
Adverse Experience
Item
Adverse Experience
text
C0877248 (UMLS CUI [1])
Onset Data and Time
Item
Onset Data and Time
datetime
C0011008 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
End Date and Time (if ongoing please leave blank)
Item
End Date and Time (if ongoing please leave blank)
datetime
C2981425 (UMLS CUI [1])
Item
Outcome- If patient died, STOP: go to SAE section and follow instructions given here
text
C1705586 (UMLS CUI [1])
Outcome
Code List
Outcome- If patient died, STOP: go to SAE section and follow instructions given here
CL Item
Resolved (1)
CL Item
Ongoing (2)
CL Item
Died (3)
Item
Experience Course
text
C0877248 (UMLS CUI [1,1])
C0750729 (UMLS CUI [1,2])
Experience Course
Code List
Experience Course
CL Item
Intermittent (number of episodes:..............) (1)
CL Item
Constant (2)
Common Toxicity Grade
Item
Common Toxicity Grade: 1-4
text
C2826262 (UMLS CUI [1])
Item
Action Taken with Respect to Investigational Drug
text
C2826626 (UMLS CUI [1])
Action Taken with Respect to Investigational Drug
Code List
Action Taken with Respect to Investigational Drug
CL Item
None (1)
CL Item
Dose reduced (2)
CL Item
Dose increased (3)
CL Item
Drug stopped (4)
CL Item
Drug interrupted/restarted (5)
CL Item
Dose delayed (6)
CL Item
Dose delayed and decreased (7)
Item
Relationship to Investigational Drug
text
C0439849 (UMLS CUI [1,1])
C3854006 (UMLS CUI [1,2])
Relationship to Investigational Drug
Code List
Relationship to Investigational Drug
CL Item
Not related (4)
CL Item
Unlikely (3)
CL Item
Suspected (reasonable possibility) (2)
CL Item
Probable (1)
Corrective Therapy
Item
If ´Yes´ record details in the Concomitant Medication section
boolean
C0877248 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
Withdrawn due to this specific AE
Item
Was patient withdrawn due to this specific AE?
boolean
C0422727 (UMLS CUI [1,1])
C1518404 (UMLS CUI [1,2])
Investigators Signature
Item
Investigators Signature
text
C2346576 (UMLS CUI [1])
Investigators Signature Date
Item
Investigators Signature Date
date
C0807937 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial